Evidence map›Paper›PMID 37153797›Full record

SynthesisFrontiers in pharmacology2023

Clinical effect of

Wei Huang, Yanling Rao, Liang Li, Chengyin Li, Yi An

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Uncovering the mechanistic basis ofPharmaceutical biology · 2025
    Article
  2. Frontiers in chemistry · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Anthraquinones fromDrug design, development and therapy · 2025
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Wei HuangHubei University of Chinese Medicine, Wuhan, China.
Yanling RaoThe Fifth Hospital of Wuhan, Wuhan, China.
Liang LiHubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China.
Chengyin LiHubei University of Chinese Medicine, Wuhan, China.
Yi AnTCM Department, Second Wuhan University of Science and Technology Hospital, Wuhan, China.
Fifth Hospital In Wuhan · CNHubei Provincial Hospital of Traditional Chinese Medicine · CNHubei University of Chinese Medicine · CNTongren Hospital · CNWuhan University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic renal failuremeta-analysisrhubarbsystematic reviewtreatment

Identifiers

PMID37153797
PMCPMC10157189
OpenAlexW4366595871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.